Found 29 matching trials
Tau Tracer Comparison in Healthy Controls and Alzheimer's Disease Patients NA The primary objective of this study is to identify a new radioligand for im...
Show More Location
John Hopkins Hospital
Learn More & Join Trial
Ultra-High Resolution PET in Aging, Neurodegeneration and Psychotic Disorders NA The goal of this study is to use ultra-high-resolution (UHR) PET imaging to...
Show More Learn More & Join Trial
Accelerated Non-Atherosclerotic Brain Arterial Aging Relationship to Alzheimer's Disease N/A The aging of the United States (US) population will lead to a steep rise in...
Show More Location
Columbia University Medical Center
Learn More & Join Trial
BioFINDER-Brown: Examination of Alzheimer's Disease Biomarkers N/A This research study aims to examine biomarkers of Alzheimer's disease as ea...
Show More Status
Enrolling By Invitation
Location
Butler Hospital Memory and Aging Program
Learn More & Join Trial
University of Washington Alzheimer's Disease Research Center (UW ADRC) Imaging & Biomarker Core N/A This is a cross-sectional, observational study that characterizes research ...
Show More Location
Multiple Locations
Learn More & Join Trial
Transcranial Photobiomodulation for Alzheimer's Disease (TRAP-AD) PHASE2 This multi-site study will be the first to evaluate the dose-dependent effe...
Show More Status
Active Not Recruiting
Location
Massachusetts General Hospital
Learn More & Join Trial
Exploring the Utility of [18F]3F4AP for Demyelination Imaging PHASE1 The overall objective is to obtain an assessment of the pharmacokinetics of...
Show More Location
Yale University PET Center
Learn More & Join Trial
Brain Imaging in the Diabetes Prevention Program Outcomes Study EARLY_PHASE1 This is a cross-sectional pilot study of Alzheimer's disease (AD) brain ima...
Show More Location
Columbia University Irving Medical Center
Learn More & Join Trial
Development of a Database to Investigate Digital and Blood-Based Biomarkers and Their Relationship to Tau and Amyloid PET Imaging in Older Participants Who Are Cognitively Normal (CN), Have Mild Cognitive Impairment (MCI), or Have Mild-to-Moderate AD Dementia N/A Bio-Hermes-002 is a 120-day cross-sectional study that will result in a blo...
Show More Location
JEM Research Institute
Learn More & Join Trial
Study of Tau Imaging With the Use of [18F]MK-6240 Tracer N/A The recent development of a PET tracer,\[18F\]MK-6240(an\[18F\]tau imaging ...
Show More Status
Enrolling By Invitation
Location
Washington University School of Medicine
Learn More & Join Trial